We are live on ! Find out more
XRAY icon

Dentsply Sirona

9.53 USD
-0.08
0.83%
At close Updated Oct 30, 4:00 PM EDT
Pre-market
After hours
9.64
+0.11
1.15%
1 day
-0.83%
5 days
1.38%
1 month
7.56%
3 months
-30.64%
6 months
-18.89%
Year to date
-15.44%
1 year
-24.31%
5 years
-83.6%
10 years
-83.45%
 

About: Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantology. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers.

Employees: 14,000

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 27.8%
Neutral 55.6%
Negative 16.7%
Neutral
PRNewsWire
4 days ago
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Neutral
GlobeNewsWire
11 days ago
Dentsply Sirona to Host Third Quarter 2026 Conference Call on November 5
CHARLOTTE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, November 5, 2026, at 4:30 p.m. EST to review its third quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call.
Dentsply Sirona to Host Third Quarter 2026 Conference Call on November 5
Positive
Zacks Investment Research
19 days ago
Dentsply Sirona Expands U.S. Digital Dentistry Reach With Midwest Deal
XRAY expands its U.S. distribution reach through Midwest Dental, aiming to boost digital dentistry adoption and broaden access to its technology portfolio.
Dentsply Sirona Expands U.S. Digital Dentistry Reach With Midwest Deal
Neutral
GlobeNewsWire
24 days ago
Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio
MÖLNDAL, Sweden, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Wellspect HealthCare today announced that the Surity™ portfolio, including the Surity™ Urinary Management System and Surity™ Female and Male External Catheters, may be covered by traditional Medicare for eligible beneficiaries when medically necessary. This milestone represents an important step in expanding access and reducing barriers to at-home management for people affected by severe urinary incontinence in the U.S.
Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio
Neutral
GlobeNewsWire
25 days ago
Dentsply Sirona Continues North American Commercial Expansion with Midwest Dental Agreement
The expanded relationship builds on a series of agreements announced this year, strengthening Dentsply Sirona's North American dealer network and giving more customers access to its products and technology. The expanded relationship builds on a series of agreements announced this year, strengthening Dentsply Sirona's North American dealer network and giving more customers access to its products and technology.
Dentsply Sirona Continues North American Commercial Expansion with Midwest Dental Agreement
Negative
Zacks Investment Research
1 month ago
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now
XRAY's digital dentistry, R&D and restructuring support growth, but CAD/CAM, implants, SureSmile and tariff pressures pose near-term risks.
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now
Positive
Zacks Investment Research
1 month ago
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
Neutral
PRNewsWire
1 month ago
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Neutral
GlobeNewsWire
1 month ago
Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference
CHARLOTTE, N.C., Sept. 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Baird 2026 Global Healthcare Conference. Management is scheduled to present on Tuesday, September 15, 2026, at 11:25 a.m. ET.
Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference
Neutral
Schwab Network
1 month ago
Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities
"I'll give you 950 billion reasons to buy bonds right now," says Thomas Hayes, who gives a contrarian take on why investors should bolster their portfolios in fixed income. He discusses the "seasonality effect," a crowded AI trade, a complicated geopolitical picture, and a steady rise in crude oil as components he sees leading a lasting bond rally.
Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities
Price charts implemented using Lightweight Charts™